CFDE Data Portal | Search CD40

	Label	Description
	CD40 Gene (Entity type)	ENSG00000101017 - CD40 molecule
	AGL Gene (Entity type)	ENSG00000162688 - amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
	SLC35A3 Gene (Entity type)	ENSG00000117620 - solute carrier family 35 member A3
	COQ2 Gene (Entity type)	ENSG00000173085 - coenzyme Q2, polyprenyltransferase
	CD40 associations Collection (Entity type)	Associations for CD40_associations
	GSE172016 2 V 5 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE229973 3 V 2 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 4 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	MAP3K1 Gene (Entity type)	ENSG00000095015 - mitogen-activated protein kinase kinase kinase 1

CD40

ENSG00000101017 - CD40 molecule

AGL

ENSG00000162688 - amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase

SLC35A3

ENSG00000117620 - solute carrier family 35 member A3

COQ2

ENSG00000173085 - coenzyme Q2, polyprenyltransferase

CD40 associations

Associations for CD40_associations

GSE172016 2 V 5 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up

A Gene Set from LINCS

GSE229973 3 V 2 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE48812 sulforaphane 4 v 10 human dn

A Gene Set from LINCS

MAP3K1

ENSG00000095015 - mitogen-activated protein kinase kinase kinase 1

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.